|
|
|
Clinical Trials at University of Chicago Comprehensive Cancer Center
Multicenter Randomized Comparative Phase III Trial of Onconase vs. Doxorubicin in Patients with Malignant Mesothelioma
Phase II Study of Capecitabine in Patients With Malignant Mesothelioma
Phase II Study of SU5416 in Patients With Unresectable Malignant Mesothelioma